_PRIVATE_LIMITED_397204.webp)
About Seagull Laboratories (India) Private Limited
Data last updated:
Seagull Laboratories (India) Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 May 1981 and has been in existence for over 45 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1981PTC011698. Its GSTIN is 02AABCS2833D2ZZ (Himachal Pradesh). The company holds 10 GST registrations, of which 3 are active.
The company has an authorised share capital of ₹75 Lakh and a paid-up capital of ₹74.5 Lakh. It is led by directors Devender Dogra (Managing Director) and Abhinav Dogra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D – 3 Lgf Lajpat Nagar – 1, New Delhi, Delhi, India – 110024.
As per the financials filed for FY 2024, the company reported a revenue of ₹13.38 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net loss of ₹61.25 Lakh (net margin -4.6%) and EBITDA of -₹49.17 Lakh (EBITDA margin -3.7%). Revenue has declined at a compounded annual rate (CAGR) of 6% over three years and 12% over five years.
The company has about 106 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Seagull Laboratories. As per MCA filings, the company has open charges of ₹12.05 Cr and satisfied charges of ₹5.16 Cr on record. Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website seagulllaboratories.in.
Company details
Contact details
Seagull Laboratories (India) Private Limited's registered office is in New Delhi, Delhi. Its website is seagulllaboratories.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressD – 3 Lgf Lajpat Nagar – 1, New Delhi, Delhi, India – 110024
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Seagull Laboratories (India) Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Seagull Laboratories (India) operates one associated brand: Seagull Laboratories. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| A pharmaceutical company manufacturing and marketing formulations for respiratory, pain relief, and skin care products. | seagulllaboratories.in |
Business activity
The main business activity of Seagull Laboratories (India) is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Seagull Laboratories (India) Private Limited, buy the company report.
Financials of Seagull Laboratories (India) Private Limited
FY 2025 filings availableSeagull Laboratories (India) Private Limited reported revenue of ₹13.38 Cr (down 2% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 12% over five years, including a 2% fall in the latest year. EBITDA fell 551% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹49.17 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹61.25 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -3.7% | ||||
| Net Profit Margin | -4.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Seagull Laboratories (India) Private Limited, buy the company report.
Board of directors of Seagull Laboratories (India) Private Limited
Seagull Laboratories (India) has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Devender Dogra Also directs: Navrit Pharmaceutical Private Limited | Managing Director | 01 Apr 1994 | 32 Years 7 Months | Current |
| Abhinav Dogra Also directs: Navrit Pharmaceutical Private Limited | Director | 31 Mar 2012 | 14 Years 7 Months | Current |
Peer comparison
Seagull Laboratories (India) Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| KNM Pharma Private Limited | ₹13.41 Cr (FY 2025) | 36.0% | Ahmedabad, Gujarat, India | |||
| Seagull Laboratories (India) Private Limitedthis company | ₹13.38 Cr (FY 2024) | -₹61.25 Lakh | -4.6% | -2.0% | 106 | New Delhi, Delhi, India |
| Medoz Pharmaceuticals Private Limited | ₹13.36 Cr (FY 2025) | 6.0% | Vadodara, Gujarat, India | |||
| Pharmacare Aura Private Limited | ₹13.33 Cr (FY 2025) | 64.0% | Paonta Sahib, Himachal Pradesh, India |
To see the full peer comparison of Seagull Laboratories (India) Private Limited, buy the company report.
Auditor
Seagull Laboratories (India) Private Limited is audited by KASHYAP SIKDAR AND CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KASHYAP SIKDAR AND CO | FY 2022 | 016253N |
Shareholding
The shareholding of Seagull Laboratories (India) Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Seagull Laboratories (India) Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 Jan 2016 | 10617178 | Others | ₹11 Cr | Open | |
| 26 Feb 2011 | 10316197 | The Nainital Bank Limited | ₹1 Cr | Open | |
| 15 Jan 2011 | 10262731 | Director of Industries Himachal Pradesh Through General Manager District Industries | ₹5.38 Lakh | Open | |
| 21 Jun 2006 | 10008422 | Hdfc Bank Ltd. | ₹2.39 Cr | Satisfied | |
| 21 Sep 1983 | 90031795 | Central Bank of India | ₹7 Lakh | Satisfied |
To see the full charge records of Seagull Laboratories (India) Private Limited, buy the company report.
Total charge records: 6 View all charges
Legal cases
Seagull Laboratories (India) Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South East, Delhi | Criminal case | Filed against the company by Radico Khitan Ltd. | Disposed |
To see the full case history of Seagull Laboratories (India) Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Seagull Laboratories (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Seagull Laboratories (India) Private Limited has a workforce of 106 employees on its EPFO records as of Nov 2025, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2025-26 | 106 |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 | |
| FY 2014-15 | |
| FY 2013-14 | |
| FY 2012-13 | |
| FY 2011-12 | |
| FY 2010-11 |
To see the full employee and EPFO history of Seagull Laboratories (India) Private Limited, buy the company report.
GST
Seagull Laboratories (India) has 10 GST registrations: 3 active and 7 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AABCS2833D2ZZ | Himachal Pradesh | Active | 01 Jul 2017 |
| 06AABCS2833D1ZS | Haryana | Active | 01 Jul 2017 |
| 09AABCS2833D2ZL | Uttar Pradesh | Active | 17 Oct 2017 |
To see the full GST registrations and return filing status of Seagull Laboratories (India) Private Limited, buy the company report.
Recent activity
Seagull Laboratories (India) Private Limited has 3 board changes on record since 1994: 2 appointments and 1 cessation. The latest: Abhinav Dogra was appointed as Director on 31 Mar 2012.
7 earlier events are in the company report.
Frequently asked questions
Seagull Laboratories (India) is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 May 1981 (45+ years old) and is registered under CIN U74899DL1981PTC011698.
Seagull Laboratories (India) has 2 current directors:
- Devender Dogra - Managing Director
- Abhinav Dogra - Director
The latest financial statements of Seagull Laboratories (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Seagull Laboratories (India) is 02AABCS2833D2ZZ, registered in Himachal Pradesh. The company has 10 GST registrations in all, of which 3 are active and 7 are cancelled or inactive. Other active GSTINs include 06AABCS2833D1ZS (Haryana), 09AABCS2833D2ZL (Uttar Pradesh).
The CIN (Corporate Identification Number) of Seagull Laboratories (India) is U74899DL1981PTC011698. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Seagull Laboratories (India) has 1 court case on record: 1 filed against it.
Seagull Laboratories (India) was incorporated on 12 May 1981, making it 45+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Seagull Laboratories (India) by revenue are KNM Pharma Private Limited, Medoz Pharmaceuticals Private Limited, Pharmacare Aura Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Abhinav Dogra was appointed as Director on 31 Mar 2012. Adarsh Kashyap ceased to be Director on 31 Mar 2012. Devender Dogra was appointed as Managing Director on 01 Apr 1994.
Seagull Laboratories (India) can be reached through the website seagulllaboratories.in. Its registered office is in New Delhi, Delhi, India.
The registered office of Seagull Laboratories (India) is at D – 3 Lgf Lajpat Nagar – 1, New Delhi, Delhi, India – 110024.

